PATENT CLAIM ANALYSIS

Application Number: 15969265
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-03
Patent Classification: ["514", "012000"]

Abstract:
The invention relates generally to methods and compositions for treating conditions associated with angiogenesis, and, more specifically, the invention relates to methods and compositions for treating conditions associated with angiogenesis using vascular adhesion protein-1 (VAP-1) inhibitors. The invention also relates to methods and compositions for treating conditions associated with lymphangiogenesis using VAP-1 inhibitors.

Claim (Index 15):
A method for treating a lymphangiogenic condition, the method comprising:\n administering a VAP-1 inhibitor to a subject in an amount sufficient to inhibit lymphangiogenesis.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 2.06897
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14758724', '09780142', '12457478', '15413991', '15058938']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.757677074787747
- 35 USC 102 Novelty (BERT): 0.5129774845761823
- Combined Prediction Score: 0.7332071157665906
- Mean Citation Score: 274.937968
- Max Citation Score: 277.0472
- Similarity Product: 177.51368091869355

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test